Maisin SA
Maisin reported total assets of €1.02m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Maisin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +5 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Maisin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 23 Sep 2025
- Year ended 31 Dec 2023filed on 24 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Maisin's financial analysis
- Solvency70.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Maisin
Maisin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.630.978
- VAT number
- BE0422630978
- Peppol
- Registered · 0208:0422630978 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 21 Apr 1982
- Registered office
- 3090 Overijse
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Maisin (SA) has been based in Overijse since 1982, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,491 € and equity of 723,863 €; its revenue is not published. Its solvency stands at 70.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Maisin
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Tennstedt-Levie Retail sale of pharmaceutical products Overijse · balance sheet 956,496 €
- PHARMACIE DE l'EDEN Retail sale of pharmaceutical products Montigny-le-Tilleul · balance sheet 954,423 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Millenium Pharma Retail sale of pharmaceutical products Ganshoren · balance sheet €1.15m
- Les Pharmacies Lambrechts Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 896,725 €
- Apo-M Retail sale of pharmaceutical products Kortenberg · balance sheet 852,674 €
- HDfarma Retail sale of pharmaceutical products Zedelgem · balance sheet 779,162 €
- Biloba Heverlee Retail sale of pharmaceutical products Leuven · balance sheet 760,814 €
Frequently asked questions about Maisin
What is the revenue of Maisin?
Maisin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Maisin?
In Belgium, the VAT number is the company number prefixed with BE: BE0422630978 for Maisin, if the company is VAT-registered. Its company number (CBE) is 0422.630.978.
Where is the registered office of Maisin?
According to the CBE register, the registered office of Maisin is in 3090 Overijse.
What is the equity of Maisin?
At the close of the 2025 financial year, the equity of Maisin amounts to 723,863 €, a solvency of 70.7% of total assets.
Who manages Maisin?
The register lists 5 active mandates at Maisin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Maisin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →